These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36412830)

  • 1. Pronounced Declines in Meperidine in the US: Is the End Imminent?
    Harrison LR; Arnet RE; Ramos AS; Chinga PA; Anthony TR; Boyle JM; McCall KL; Nichols SD; Piper BJ
    Pharmacy (Basel); 2022 Nov; 10(6):. PubMed ID: 36412830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declines and pronounced regional disparities in meperidine use in the United States.
    Boyle JM; McCall KL; Nichols SD; Piper BJ
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00809. PubMed ID: 34128348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in adverse drug events of opioids in the United States.
    Liu EY; McCall KL; Piper BJ
    Front Pharmacol; 2023; 14():1163976. PubMed ID: 37033633
    [No Abstract]   [Full Text] [Related]  

  • 4. Declines and regional variation in opioid distribution by U.S. hospitals.
    Eidbo SA; Kropp Lopez AK; Hagedorn JD; Mathew V; Kaufman DE; Nichols SD; McCall KL; Piper BJ
    Pain; 2022 Jun; 163(6):1186-1192. PubMed ID: 34510133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in prescription opioids from 2006 to 2017 in Texas.
    Ighodaro EO; McCall KL; Chung DY; Nichols SD; Piper BJ
    PeerJ; 2019; 7():e8108. PubMed ID: 31824762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the Distribution of Opioids in Puerto Rico, 1999-2013.
    El Burai Félix S; Mack KA; Jones CM
    P R Health Sci J; 2016 Sep; 35(3):165-9. PubMed ID: 27623143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductions and pronounced regional differences in morphine distribution in the United States.
    Dowd ME; Tang EJ; Yan KT; McCall KL; Piper BJ
    Res Social Adm Pharm; 2023 Jun; 19(6):926-930. PubMed ID: 36894400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid distribution trends (2006-2017) in the US Territories.
    Cabrera FF; Gamarra ER; Garcia TE; Littlejohn AD; Chinga PA; Pinentel-Morillo LD; Tirado JR; Chung DY; Pande LJ; McCall KL; Nichols SD; Piper BJ
    PeerJ; 2019; 7():e6272. PubMed ID: 30671308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining but Pronounced State-Level Disparities in Prescription Opioid Distribution in the United States.
    Madera JD; Ruffino AE; Feliz A; McCall KL; Davis CS; Piper BJ
    Pharmacy (Basel); 2024 Jan; 12(1):. PubMed ID: 38251408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Medical Use of Opioids in the U.S., 2006-2016.
    Piper BJ; Shah DT; Simoyan OM; McCall KL; Nichols SD
    Am J Prev Med; 2018 May; 54(5):652-660. PubMed ID: 29551331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
    Atluri S; Sudarshan G; Manchikanti L
    Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in medical use and abuse of opioid analgesics.
    Joranson DE; Ryan KM; Gilson AM; Dahl JL
    JAMA; 2000 Apr; 283(13):1710-4. PubMed ID: 10755497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization, Spending, and Price of Opioid Medications in the US Medicaid Programs Between 1991 and 2019.
    Alsultan MM; Guo JJ
    Am Health Drug Benefits; 2022 Mar; 15(1):31-37. PubMed ID: 35586617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010.
    Kenan K; Mack K; Paulozzi L
    Open Med; 2012; 6(2):e41-7. PubMed ID: 23696768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eliminating analgesic meperidine use with a supported formulary restriction.
    O'Connor AB; Lang VJ; Quill TE
    Am J Med; 2005 Aug; 118(8):885-9. PubMed ID: 16084182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of meperidine prescribing in older adults: A longitudinal population-based study.
    Friesen KJ; Falk J; Bugden S
    BMC Geriatr; 2016 May; 16():100. PubMed ID: 27170170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.